Cordyceps Sunshine Biotech Holdings RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

Cordyceps Sunshine Biotech Holdings (RAJAF) EBT (2021 - 2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) posted quarterly EBT of $83430.0 for Q4 2023, up 326.15% year-over-year from $19577.5 in Q4 2022, and up 326.15% quarter-over-quarter from -$36891.0 in Q4 2022.

Cordyceps Sunshine Biotech Holdings (RAJAF) EBT (2021 - 2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' EBT history runs 3 years deep, the most recent figure standing at $83430.0 for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Kraft Heinz 30.33 Bn 27.65 Bn 2.03 Bn -6.38 Bn
2 General Mills 21.40 Bn 20.94 Bn 1.60 Bn -2.23 Bn
3 Mccormick 15.03 Bn 14.70 Bn 778.20 Mn 220.20 Mn
4 Jbs 14.89 Bn 11.42 Bn 4.91 Bn -222.08 Mn
5 J M Smucker 13.23 Bn 13.17 Bn 862.10 Mn 327.60 Mn
6 Hormel Foods 13.19 Bn 12.33 Bn 518.51 Mn 206.06 Mn
7 Magnum Ice Cream 12.13 Bn 11.41 Bn - -
8 Darling Ingredients 10.45 Bn 10.29 Bn 503.37 Mn 499.91 Mn
9 Smithfield Foods 8.78 Bn 7.43 Bn 478.00 Mn 299.00 Mn
10 Cordyceps Sunshine Biotech Holdings 1.02 Bn 1.02 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 83,430.00
Dec 31, 2022 -36,891.00
Dec 31, 2021 -176,212.00